Birchview Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$757K	Sell	67,000 -2	-0%	-$23	0.75%	30
2025 Q1	$773K	Buy	67,002 +2	+0%	+$23	0.67%	25
2024 Q4	$567K	Sell	67,000 -15,000	-18%	-$127K	0.46%	29
2024 Q3	$950K	Buy	82,000 +36,000	+78%	+$417K	0.82%	24
2024 Q2	$542K	Hold	46,000	–	–	0.5%	29
2024 Q1	$546K	Buy	46,000 +6,000	+15%	+$71.2K	0.44%	34
2023 Q4	$490K	Hold	40,000	–	–	0.38%	34
2023 Q3	$385K	Hold	40,000	–	–	0.33%	35
2023 Q2	$360K	Hold	40,000	–	–	0.27%	42
2023 Q1	$314K	Hold	40,000	–	–	0.25%	42
2022 Q4	$270K	Hold	40,000	–	–	0.19%	44
2022 Q3	$580K	Hold	40,000	–	–	0.41%	36
2022 Q2	$394K	Hold	40,000	–	–	0.29%	43
2022 Q1	$590K	Hold	40,000	–	–	0.42%	38
2021 Q4	$529K	Hold	40,000	–	–	0.34%	42
2021 Q3	$698K	Hold	40,000	–	–	0.48%	34
2021 Q2	$958K	Hold	40,000	–	–	0.57%	33
2021 Q1	$1.03M	Buy	40,000 +10,000	+33%	+$257K	0.61%	28
2020 Q4	$570K	Hold	30,000	–	–	0.33%	38
2020 Q3	$378K	Hold	30,000	–	–	0.25%	38
2020 Q2	$363K	Hold	30,000	–	–	0.22%	43
2020 Q1	$230K	Hold	30,000	–	–	0.2%	40
2019 Q4	$534K	Hold	30,000	–	–	0.39%	34
2019 Q3	$348K	Buy	+30,000	New	+$348K	0.23%	35